Danielle Gronich is a seasoned executive with extensive experience in the skincare and healthcare industries. As the Chief Executive Officer of CLEARSTEM Skincare since January 2016, Danielle Gronich oversees formulation, product development, and strategic growth initiatives. Additionally, Danielle serves as an investor and advisor for Toto, where the focus is on the transformative impact of adaptogens following founder Sydney Webb's colon cancer diagnosis. Danielle also holds the position of CEO and Founder at San Diego Acne Clinic and previously worked as a Strategic Business Advisor and District Manager at ADP, specializing in operational efficiency and talent management. Danielle Gronich began their career in sales and marketing at Priority Pharmaceuticals Inc and holds a Bachelor's degree in Sociology from UC Santa Barbara.